Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported IDR Q1 2026 Earnings EPS Miss Weighs on Shares as Strategic Priorities Continue Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress YORW Q1 2026 Earnings EPS Surpasses Estimates as Utility Delivers Steady Performance DOC Q1 2026 Earnings Massive EPS Beat of 515 Surprises Analysts CNX Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency